Taste and smell disturbances in cancer patients: a scoping review of available treatments
Authors:
- 30 July 2020
- journal article
- review article
- Published by Springer Nature in Supportive Care in Cancer
- Vol. 29 (1) , 49-66
Abstract
Purpose Taste and smell disturbances in patients affected by cancer are very common, but often under-recognized symptoms. If not addressed properly, they may impact nutritional status, food enjoyment, and quality of life. Treatment tools available for clinicians to manage chemosensory alterations are limited and are often based on personal clinical experiences. The aim of this study was to assess current oncological and palliative care literature through a scoping review, in order to identify available treatments for taste and smell alterations in cancer patients. Methods Medline, Embase, CINAHL, ProQuest Dissertations and Theses, and Google Scholar were searched from inception until January 2020, with subject headings relevant to the domains of chemosensory alterations, palliative, and cancer care. A total of 10,718 English and French language publications were reviewed, yielding 43 articles on the researched topic. Results The heterogeneity of selected articles led to difficulties in interpretation and analysis of the available evidence. Included publications differed in study design, population sample, anticancer treatments, and measures of assessment for taste and smell disturbances. A broad variety of treatment options were described including zinc and polaprezinc, radio-protectors, vitamins and supplements, anti-xerostomia agents, active swallowing exercises, nutritional interventions, delta-9-tetrahydrocannabinol, and photobiomodulation. Conclusion This scoping review identifies the current state of knowledge regarding chemosensory alterations within supportive cancer care. Despite not reaching firm conclusions, this article offers therapeutic venues to further explore in larger and more methodologically sound studies.Keywords
This publication has 59 references indexed in Scilit:
- A Randomized, Placebo Controlled Trial of Oral Zinc for Chemotherapy-Related Taste and Smell DisordersJournal of Pain & Palliative Care Pharmacotherapy, 2012
- Role of Lipid Oxidation, Chelating Agents, and Antioxidants in Metallic Flavor Development in the Oral CavityJournal of Agricultural and Food Chemistry, 2012
- Polaprezinc prevents oral mucositis associated with radiochemotherapy in patients with head and neck cancerInternational Journal of Cancer, 2010
- Self-Care Strategies to Cope With Taste Changes After ChemotherapyOncology Nursing Forum, 2009
- Prevention of Docetaxel- or Paclitaxel-Associated Taste Alterations in Cancer Patients with Oral Glutamine: A Randomized, Placebo-Controlled, Double-Blind StudyThe Oncologist, 2008
- Drug-Induced Taste DisordersDrug Safety, 2008
- The Effect of Education in Managing Side Effects in Women Receiving Chemotherapy for Treatment of Breast CancerOncology Nursing Forum, 2004
- Taste, smell and neuropsychological performance of individuals at familial risk for Alzheimer's diseaseNeurobiology of Aging, 2002
- Novel therapeutic approaches to gastric and duodenal ulcers: an updateExpert Opinion on Investigational Drugs, 2000
- Treatment of radiation side effects with oral pilocarpineJournal of Surgical Oncology, 1989